Bluejay Therapeutics Organization Context

JSON-LD context defining the semantic vocabulary for Bluejay Therapeutics Organization from Bluejay Therapeutics.
0 Classes 0 Properties 0 Namespaces
JSON-LD Document

{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "@id": "https://bluejaytx.com/#breadcrumblist",
      "itemListElement": [
        {
          "@type": "ListItem",
          "@id": "https://bluejaytx.com#listItem",
          "position": 1,
          "name": "Home"
        }
      ]
    },
    {
      "@type": "Organization",
      "@id": "https://bluejaytx.com/#organization",
      "name": "Bluejay Therapeutics",
      "description": "Creating a new paradigm for viral and liver diseases.",
      "url": "https://bluejaytx.com/",
      "logo": {
        "@type": "ImageObject",
        "url": "https://bluejaytx.com/wp-content/uploads/2023/01/BluejayTx_Logo.png",
        "@id": "https://bluejaytx.com/#organizationLogo",
        "width": 400,
        "height": 400
      },
      "image": {
        "@id": "https://bluejaytx.com/#organizationLogo"
      },
      "sameAs": [
        "https://www.linkedin.com/company/bluejay-therapeutics/"
      ]
    },
    {
      "@type": "WebPage",
      "@id": "https://bluejaytx.com/#webpage",
      "url": "https://bluejaytx.com/",
      "name": "Bluejay Therapeutics",
      "description": "January 26, 2026Mirum Pharmaceuticals Completes Acquisition of Bluejay TherapeuticsFor the latest information on brelovitug and to follow Mirum's work in chronic hepatitis delta virus and rare diseases, visit https://mirumpharma.com -",
      "inLanguage": "en-US",
      "isPartOf": {
        "@id": "https://bluejaytx.com/#website"
      },
      "breadcrumb": {
        "@id": "https://bluejaytx.com/#breadcrumblist"
      },
      "datePublished": "2026-01-26T05:06:56-08:00",
      "dateModified": "2026-01-26T05:33:27-08:00"
    },
    {
      "@type": "WebSite",
      "@id": "https://bluejaytx.com/#website",
      "url": "https://bluejaytx.com/",
      "name": "Bluejay Therapeutics",
      "description": "Creating a new paradigm for viral and liver diseases.",
      "inLanguage": "en-US",
      "publisher": {
        "@id": "https://bluejaytx.com/#organization"
      }
    }
  ]
}